Literature DB >> 16082606

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Wassim Y Almawi1, Hala Tamim, Raghid Kreidy, Georgina Timson, Elias Rahal, Malak Nabulsi, Ramzi R Finan, Noha Irani-Hakime.   

Abstract

BACKGROUND: Insofar as the inherited prothrombotic single nucleotide polymorphisms (SNPs) factor V G1691A (FV-Leiden), prothrombin (PRT) G20210A, and methylenetetrahydrofolate reductase (MTHFR), C677T are inherited risk factors of venous thromboembolism (VTE), the aim of this study was to determine the prevalence of single and combined SNPs in 198 patients with documented deep venous thrombosis (DVT), and 697 control subjects, and to estimate the associated risks.
METHODS: Factor V-Leiden, PRT G20210A, and MTHFR C677T were analyzed by PCR and restriction fragment length polymorphism (RFLP).
RESULTS: The prevalence of the heterozygote and homozygous variants for FV-Leiden (52.02 vs. 14.78%, RR 6.28), PRT G20210A (19.2 vs. 3.6%; RR 6.38), and to a lesser extent the T/T genotype of MTHFR C677T (20.71 vs. 11.0%; RR 1.49) were higher among DVT patients vs. controls, respectively. Two or more SNPs were detected in 90 of 198 patients (45.5%) and in 60 of 697 controls (8.6%), with odds ratios of 16.754 for joint occurrence of FV-Leiden and PRT G20210A, 10.471 for FV-Leiden and MTHFR C677T, and 6.283 for PRT G20210A SNPs and MTHFR 677T/T. Logistic regression analysis showed a further increased odds for FV-Leiden in combination with PRT G20210A (85.198) or homozygous MTHFR C677T (81.133), and to a lesser extent for PRT G20210A in combination with homozygous MTHFR C677T (20.812).
CONCLUSIONS: This indicates that FV-Leiden and PRT G20210A, more than MTHFR C677T, are important risk factors for DVT, and that the presence of more than one prothrombotic SNPs was associated with a significant risk of DVT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082606     DOI: 10.1007/s11239-005-1313-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  42 in total

1.  High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation?

Authors:  A Taher; I Khalil; A Shamseddine; F El-Ahdab; A Bazarbachi
Journal:  Thromb Haemost       Date:  2001-08       Impact factor: 5.249

2.  A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506).

Authors:  M Cattaneo; M Y Tsai; P Bucciarelli; E Taioli; M L Zighetti; M Bignell; P M Mannucci
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

3.  Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia.

Authors:  H Fujimura; T Kawasaki; T Sakata; H Ariyoshi; H Kato; M Monden; T Miyata
Journal:  Thromb Res       Date:  2000-04-01       Impact factor: 3.944

4.  The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.

Authors:  M Margaglione; G D'Andrea; M d'Addedda; N Giuliani; G Cappucci; L Iannaccone; G Vecchione; E Grandone; V Brancaccio; G Di Minno
Journal:  Thromb Haemost       Date:  1998-05       Impact factor: 5.249

5.  Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.

Authors:  D Gemmati; M L Serino; S Moratelli; S Tognazzo; A Ongaro; G L Scapoli
Journal:  Haemostasis       Date:  2001 Mar-Apr

6.  Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis.

Authors:  P Simioni; P Prandoni; A W Lensing; D Manfrin; D Tormene; S Gavasso; B Girolami; C Sardella; M Prins; A Girolami
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

Authors:  O Salomon; D M Steinberg; A Zivelin; S Gitel; R Dardik; N Rosenberg; S Berliner; A Inbal; A Many; A Lubetsky; D Varon; U Martinowitz; U Seligsohn
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

8.  Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease.

Authors:  F Couturaud; E Oger; J H Abalain; E Chenu; B Guias; H H Floch; B Mercier; D Mottier; C Leroyer
Journal:  Respiration       Date:  2000       Impact factor: 3.580

9.  World distribution of factor V Leiden.

Authors:  D C Rees; M Cox; J B Clegg
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

Review 10.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

View more
  17 in total

1.  Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study.

Authors:  Juergen Ringwald; Annika Berger; Werner Adler; Cornelia Kraus; Rocco P Pitto
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

2.  Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.

Authors:  Benedetto Simone; Valerio De Stefano; Emanuele Leoncini; Jeppe Zacho; Ida Martinelli; Joseph Emmerich; Elena Rossi; Aaron R Folsom; Wassim Y Almawi; Pierre Y Scarabin; Martin den Heijer; Mary Cushman; Silvana Penco; Amparo Vaya; Pantep Angchaisuksiri; Gulfer Okumus; Donato Gemmati; Simona Cima; Nejat Akar; Kivilcim I Oguzulgen; Véronique Ducros; Christoph Lichy; Consuelo Fernandez-Miranda; Andrzej Szczeklik; José A Nieto; Jose Domingo Torres; Véronique Le Cam-Duchez; Petar Ivanov; Carlos Cantu-Brito; Veronika M Shmeleva; Mojka Stegnar; Dotun Ogunyemi; Suhair S Eid; Nicola Nicolotti; Emma De Feo; Walter Ricciardi; Stefania Boccia
Journal:  Eur J Epidemiol       Date:  2013-07-31       Impact factor: 8.082

3.  Personalized healthcare in clotting disorders.

Authors:  Haifeng M Wu; Lihui Xu; Daniel D Sedmak; Clay B Marsh; Mark W Wurster
Journal:  Per Med       Date:  2010-01       Impact factor: 2.512

4.  Race differences in the prevalence of the factor V Leiden mutation in Kuwaiti nationals.

Authors:  Ali A Dashti; Mehrez M Jadaon
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

5.  ABO blood groups and genetic risk factors for thrombosis in Croatian population.

Authors:  Irena Jukic; Jasna Bingulac-Popovic; Vesna Dogic; Ivana Babic; Jelena Culej; Maja Tomicic; Tomislav Vuk; Dorotea Sarlija; Melita Balija
Journal:  Croat Med J       Date:  2009-12       Impact factor: 1.351

6.  Risk factors for thrombophilia in young adults presenting with thrombosis.

Authors:  Osman Yokus; Murat Albayrak; Ozlem Sahin Balcik; Funda Ceran; Simten Dagdas; Mesude Yilmaz; Gulsum Ozet
Journal:  Int J Hematol       Date:  2009-11-25       Impact factor: 2.490

7.  Thrombophilic abnormalities in patients with or without pulmonary embolism following elective spinal surgery: a pilot study.

Authors:  Suhel Kotwal; Satoshi Kawaguchi; Alexander Hughes; Frank Cammisa; Kai Zhang; Eduardo Salvati; Federico Girardi
Journal:  HSS J       Date:  2013-01-24

8.  The importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism.

Authors:  Cristina Hotoleanu; Adrian Trifa; Radu Popp; Daniela Fodor
Journal:  Balkan Med J       Date:  2013-06-01       Impact factor: 2.021

9.  Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients?

Authors:  R Kreidy; N Irani-Hakime
Journal:  Vasc Health Risk Manag       Date:  2009-08-06

10.  Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores).

Authors:  Claudia C Branco; Tânia Pereirinha; Rita Cabral; Paula R Pacheco; Luisa Mota-Vieira
Journal:  Thromb J       Date:  2009-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.